HIKAL
|
The Current P/S Ratio of HIKAL is 1.60.
| Share Price | ₹222.2 | Jul 03,2026 |
| Market Cap | ₹2,739.7 Cr | |
| Sales-TTM | ₹1,712.6 Cr | TTM-Consolidated Results |
| Price/Sales | 1.60x | Calculated as Market Cap/Sales |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PS (Price/Sales) ratio of HIKAL
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹2,739.7 Cr] as on Jul 03,2026
(/) Sales [ ₹1,712.6 Cr] based on TTM-Consolidated Results
(=) P/S Ratio [ 1.60x ]
Thus, for HIKAL , the investors are currently willing to pay '1.60 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of HIKAL !
The chart below summarizes the trend in P/S Ratio of HIKAL over the last five years.
Historical PS (Price/Sales) ratio chart of HIKAL
PS Ratio Performance Analysis for HIKAL
- HIKAL 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 1.96x.
- HIKAL 's operated at median p/e ratio of 1.83x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, HIKAL 's p/e ratio peaked in Mar2025 at 2.66x.
- HIKAL 's p/e ratio hit its five-year low in Mar2021 of 1.03x.
How does HIKAL 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
|---|---|---|---|
| HIKAL | 1,712.6 | 1.60 | 2,739.7 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 58,462.0 | 7.82 | 456,989.0 |
| DIVIS LABORATORIES LTD | 10,560.0 | 17.00 | 179,471.0 |
| TORRENT PHARMACEUTICALS LTD | 13,980.0 | 11.54 | 161,290.0 |
| CIPLA LTD | 28,162.6 | 4.18 | 117,820.0 |
| DR REDDYS LABORATORIES LTD | 33,700.2 | 3.40 | 114,730.0 |
| MANKIND PHARMA LTD | 14,277.6 | 7.32 | 104,535.0 |
| LUPIN LTD | 27,958.0 | 4.05 | 113,215.0 |
| ZYDUS LIFESCIENCES LTD | 27,148.4 | 4.19 | 113,815.0 |
| AUROBINDO PHARMA LTD | 33,653.1 | 2.77 | 93,217.0 |
| LAURUS LABS LTD | 6,812.9 | 12.23 | 83,293.0 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs HIKAL 's P/S Ratio
| Top 10 Industry Peers | PS Ratio |
|---|---|
| Min industry PS | 1.60x |
| Max industry PS | 17.00x |
| Median industry PS | 4.19x |
| Average industry PS | 6.92x |
You may also like the below Video Courses